ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CODX Co Diagnostics Inc

1.2646
0.0046 (0.37%)
After Hours
Last Updated: 21:00:12
Delayed by 15 minutes
Share Name Share Symbol Market Type
Co Diagnostics Inc NASDAQ:CODX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.0046 0.37% 1.2646 1.23 1.30 1.29 1.22 1.25 39,286 21:00:12

Amended Statement of Changes in Beneficial Ownership (4/a)

08/06/2020 8:16pm

Edgar (US Regulatory)


FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Durenard Eugene
2. Issuer Name and Ticker or Trading Symbol

Co-Diagnostics, Inc. [ CODX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

2401 S. FOOTHILL DRIVE SUITE D
3. Date of Earliest Transaction (MM/DD/YYYY)

5/20/2020
(Street)

SALT LAKE CITY, UT 84109
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

6/5/2020 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 5/20/2020  S  25000 D$18.03 (1)25000 D  
Common Stock 5/26/2020  S  25000 D$18.24 (2)0 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) $18.03 is the weighted average price for a range of purchases between $17.90 and $18.63. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. The original Form 4, filed on June 5, 2020, was filed as a result of the printer's error and without authorization. As a result of this administrative error, the weighted average price was misreported.
(2) $18.24 is the volume-weighted average price for a range of purchases between $18.17 and $18.34. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. The original Form 4, filed on June 5, 2020, was filed as a result of the printer's error and without authorization. As a result of this administrative error, the weighted average price was misreported.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Durenard Eugene
2401 S. FOOTHILL DRIVE SUITE D
SALT LAKE CITY, UT 84109
X



Signatures
/s/ Eugene Durenard6/8/2020
**Signature of Reporting PersonDate

1 Year Co Diagnostics Chart

1 Year Co Diagnostics Chart

1 Month Co Diagnostics Chart

1 Month Co Diagnostics Chart

Your Recent History

Delayed Upgrade Clock